Image For Activity Cover
2024 HFSA AHFTC Board Certification Review - OnDemand

The HFSA AHFTC Board Certification Review 2024 (Live Access) features the pre-recorded presentations and recorded live sessions from the course, providing in-depth insights into advanced heart failure and transplant cardiology.

Designed to support preparation for the ABIM Advanced Heart Failure and Transplant Cardiology Board Certification and Maintenance of Certification Exams, this resource includes a curated Question Bank and reading list. Attendees can also complete course evaluations to claim credits.

Note: This will be continuously updated with additional recordings and resources as they become available.

The 2024 HFSA AHFTC Board Certification Review is designed for physicians who are preparing to take the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination or the Maintenance of Certification Assessment Examination, or heart failure specialists seeking an in-depth review in heart failure.

For the Certification Examination in Advanced Heart Failure and Transplant Cardiology:

This course is designed to:

  1. Review testable content and the focus of the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination.
  2. Identify gaps in knowledge about advanced heart failure and transplant cardiology.
  3. Explain how to best focus study efforts on filling identified knowledge gaps.
  4. Provide practice for the certification examination with ABIM-style multiple-choice test questions.
For Clinical Practice:
  1. Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure.
  2. Discuss the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms.
  3. Assess and treat patients with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
  4. Apply guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices.
  5. Incorporate appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, valvular heart disease, pregnancy-associated disease, and cardiorenal syndrome.
  6. Manage comorbidities in patients with chronic heart failure, including sleep-disordered breathing, anemia, and diabetes.
  7. Implement strategies for effective disease management of patients with advanced heart failure, including referral for mechanical circulatory support, heart transplant, or palliative care.
  8. Manage immunosuppressive therapies and common complications of heart transplant, including rejection, allograft vasculopathy, and immunosuppression-associated conditions.
  9. Utilize mechanical support devices, both temporary and durable.
  10. Manage common complications of mechanical circulatory support.
  • Heart Failure Epidemiology and Risk Factors - Clyde Yancy
  • Pathophysiology 1: Cellular and Energetic Considerations - Daniel Burkhoff
  • Pathophysiology 2: Hemodynamic, Structural and Neurohormonal Considerations - Daniel Burkhoff
  • Diagnosis and Clinical Assessment - Mark Drazner
  • Cardio-Oncology for the HF Boards - Bonnie Ky
  • Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards - Jon Lomasney
  • Statistics for the HF Board - Brian Claggett
  • Hemodynamics in HF I - James Fang
  • Diabetes and COPD - Maria Rosa Costanzo
  • RV Failure and TR Management - Barry Borlaug
  • Management of Comorbidities in Heart Failure - Sleep Disorders - Maria Rosa Costanzo
2024 HFSA AHFTC Board Certification Review
Access to 2024 HFSA AHFTC Board Certification Review OnDemand presentations will be available 2 weeks after the conclusion of the live course.
  • Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions) - Akshay Desai
  • Hemodynamics in HF II - James Fang
  • Optimal Medical Therapy for HFrEF 1 - Mark Drazner
  • Optimal Medical Therapy for HFrEF 2 - Mark Drazner
  • Cardio Renal Failure Interactions in Heart Failure - Wendy McCallum
  • Assessment of Functional Capacity including cardiopulmonary exercise testing - Gregory Lewis
  • HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards) - Sanjiv Shah
  • Management of Comorbidities in Heart Failure: Iron Deficiency/Anemia - Gregory Lewis
  • Pulmonary Hypertension - Classification and Initial Evaluation - Jonathan Rich
  • Pulmonary Hypertension – Treatment - Jonathan Rich
  • Specific Etiologies of HF 1: HCM - Jane Wilcox
  • Specific Etiologies of HF 2: Other Inherited HF syndromes - Jane Wilcox
  • Specific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP - Sanjiv Shah
  • Specific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies - Maria Rosa Costanzo
  • Management of the Hospitalized HF Patient - Maria Rosa Costanzo
  • Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies - Nancy Sweitzer
  • Immunology: The Basics, PRA, Sensitization, Crossmatch - Sean Pinney
  • Rejection: Cellular and Antibody Mediated - Sean Pinney
  • Heart Transplant, Clinical Outcomes and Complications - Michelle Kittleson
  • Managing Immunosuppression and Drugs - Michelle Kittleson
  • Pregnancy in HF - Kathryn Lindley
  • Cardiogenic Shock Management - Nancy Sweitzer
  • MCS 1: Durable MCS Devices and Outcomes - Joseph Rogers
  • MCS 2: Temporary Support Devices and ECMO for the Boards - Manreet Kanwar
  • MCS 3: Management of complications of MCS - Manreet Kanwar
  • MCS 4: Interactive Shock and Device Management - Daniel Burkhoff, Manreet Kanwar, Joseph Rogers, Nancy Sweitzer
  • Adult Congenital Heart Disease for the HF Specialist - Eric Krieger
  • Management of Left Sided Valvular Heart Disease in Heart Failure - Jane Wilcox
  • Management of Common Arrhythmias 1 – Atrial Fibrillation and Flutter - Roderick Tung
  • Management of Common Arrhythmias 2 – Ventricular Arrhythmia - Roderick Tung
  • Device Therapy in Heart Failure I - Sudden Death Prevention - Christine Albert
  • Device Therapy in Heart Failure II - CRT - Christine Albert
View complete program information.
Live Event Dates: July 12-14, 2024
Availability: On-Demand
Expires on Jul 15, 2025
Cost: Trainee member's rate is $1,199.00
Credit Offered:
25.5 CME Credits
25.5 MOC Points
Contains: 6 Courses
Powered by Oasis.